Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Cytopathology ; 33(3): 344-349, 2022 05.
Article in English | MEDLINE | ID: mdl-34957617

ABSTRACT

INTRODUCTION: Molecular testing for genetic alterations in thyroid neoplasms, including BRAF V600E (BRAF) mutation, are often applied to thyroid aspirates falling into the Bethesda System for Reporting Thyroid Cytopathology indeterminate categories. Current methods typically use dedicated aspirated material, without morphological determination of containing the cells of interest and may be of elevated cost. We describe our experience with BRAF mutation analysis on material obtained from Papanicolaou (PAP)-stained ThinPrep® (TP) slides. METHODS: Eighty-three cases collected between 2012 and 2019 with more than 100 cells were selected. An electronic record of a whole slide scan was made for each case before testing. The coverslips were removed, and DNA was extracted from material scraped from each slide using the Qiagen QIAamp DNA FFPE Tissue Kit. BRAF testing was performed using a highly sensitive mutation detection assay, either COLD-PCR, castPCR, or droplet digital PCR. RESULTS: Fourteen out of 83 cases had a BRAF mutation. Of these, 8 were classified as atypia of undetermined significance or suspicious for malignancy in which follow-up showed conventional papillary thyroid carcinoma in 5 out of 6 cases. The specificity and positive predictive value were 97% and 91%, respectively. CONCLUSIONS: BRAF mutation analysis can be performed on material obtained from routine clinical PAP-stained TP slides. As a first step, this unconventional effective approach may reduce costs related to the molecular evaluation of thyroid nodule aspirates and provides the opportunity for cytomorphological confirmation that the cells of interest are present in material submitted for BRAF mutation analysis.


Subject(s)
Thyroid Neoplasms , Thyroid Nodule , DNA Mutational Analysis , Humans , Mutation/genetics , Proto-Oncogene Proteins B-raf/genetics , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology , Thyroid Nodule/pathology
2.
J Am Soc Cytopathol ; 10(1): 47-55, 2021.
Article in English | MEDLINE | ID: mdl-33039333

ABSTRACT

INTRODUCTION: The utility of cell block (CB) preparation is well established in cytopathology. Despite 23.3% of College of American Pathologists-accredited laboratories using CB with liquid-based preparations on urine cytology (UC) cases, there are very few studies on their performance. To determine their usefulness, we conducted a retrospective review of UC cases that received CB. MATERIALS AND METHODS: We identified 27 UC cases with ThinPrep (TP) and CB preparation between 2016 and 2020 at our institution. Clinical history and follow-up data were compiled. A blinded review of TP alone, and TP together with CB, was performed by 2 pathologists and 2 cytotechnologists. Diagnoses were rendered in accordance with The Paris System for Reporting Urine Cytology. RESULTS: Blood and acute inflammation were common background elements in cases that received CB preparation. In total, CB upgraded the diagnosis in 7 of 27 cases (26%). The maximum utility of CB preparation was seen in indeterminate cases where 60% (6 of 10) were upgraded, including 71% (5 of 7) of atypical urothelial cells (AUC) and 30% (1 of 3) of suspicious for high-grade urothelial carcinoma (HGUC). One case (1 of 12, 8%) diagnosed as negative for HGUC on TP was diagnosed as low-grade urothelial neoplasia on CB. CONCLUSIONS: Our results demonstrate that adjunct use of CB preparation aids in a definitive diagnosis on AUC category and may be helpful in cases with cell clusters or tissue fragments, or cases suspicious for HGUC. Further correlation studies are warranted in this area to expand our knowledge about the utility of CBs in urine cytology.


Subject(s)
Carcinoma/pathology , Early Detection of Cancer , Specimen Handling , Urinary Bladder Neoplasms/pathology , Urine/cytology , Urothelium/pathology , Adult , Aged , Aged, 80 and over , Carcinoma/urine , Female , Humans , Male , Microscopy , Middle Aged , Neoplasm Grading , Pilot Projects , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Urinalysis , Urinary Bladder Neoplasms/urine
3.
J Am Soc Cytopathol ; 10(1): 56-63, 2021.
Article in English | MEDLINE | ID: mdl-33132054

ABSTRACT

INTRODUCTION: Urothelial carcinoma (UC) requires lifelong monitoring, commonly through urinary cytology and cystoscopy. Urine cytology has a relatively high sensitivity for detecting high-grade urothelial carcinoma (HGUC); however, its sensitivity for low-grade urothelial neoplasm (LGUN) is significantly lower with wide interobserver variability. The Paris System (TPS) was proposed to create standardized diagnostic categories with defined cytomorphologic criteria. We attempt to evaluate diagnostic efficacy of identifying UC using TPS through cytologic-histologic correlation. MATERIALS AND METHODS: A retrospective search identified 170 cases of urine cytology cases with concurrent biopsies collected during a 2-year time period at University of Rochester Medical Center. Patient age, sex, smoking history, prior malignancy diagnoses, cystoscopy findings, specimen collection method, UroVysion results, and 1-year follow-up of surgical pathology cases were included. RESULTS: Cytologic-histologic correlation was identified in 59% of cases, with 18% true positives and 41% true negatives. Discordant results were identified in 41% of cases; of these, 4% were false positives, 11% false negatives, 12% potential sampling bias, and 14% were low-grade urothelial carcinoma (LGUC). The analysis of this 2-year study finds a positive predictive value of urine cytology for HGUC to be 81%, a negative predictive value of 79%, a sensitivity of 61%, a specificity of 91%, and an accuracy of 79%. CONCLUSIONS: Our results support TPS's ability to improve the reliability and accuracy of interpretations in urine cytology for HGUC. Nevertheless, additional studies are essential to improve the diagnostic accuracy of LGUN, and urine adequacy, in order to improve patient care and early detection, while identifying potential sampling bias.


Subject(s)
Carcinoma/pathology , Early Detection of Cancer , Urine/cytology , Urologic Neoplasms/pathology , Urothelium/pathology , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma/surgery , Carcinoma/urine , Databases, Factual , Female , Humans , Male , Microscopy , Middle Aged , Neoplasm Grading , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Urinalysis , Urologic Neoplasms/surgery , Urologic Neoplasms/urine , Young Adult
4.
Diagn Cytopathol ; 49(1): E31-E35, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32770824

ABSTRACT

BACKGROUND: Adenoid cystic carcinoma (AdCC) is an uncommon malignancy of the salivary gland characterized by slow growth, increased risk of recurrence and poor prognosis. The annual incidence in the United States is approximately 1200 cases per year and rarely involves the body cavities. CASE PRESENTATION: We present a case of a 48-year-old male diagnosed with AdCC of the left submandibular gland. He received his last chemotherapy in 2006 and presented with pleural metastasis. After undergoing pleurectomy and decortication procedure, pericardial fluid and biopsies from the chest wall, sixth rib, diaphragm, pleural cavity and pericardium were sent for pathologic evaluation. A diagnosis of metastatic adenoid cystic carcinoma was confirmed, including in the pericardium, pericardial fluid and diaphragm. CONCLUSION: AdCC of the submandibular gland is a malignant tumor with a high mortality rate. It is very rare for AdCC to metastasize to the pericardium and diaphragm. Metastasis to uncommon sites such as seen in our case with metastases to the pericardium and diaphragm shows the aggressive and unpredictable nature of this tumor, requiring close follow up, and indicating the need for molecular profile analysis and biomarker-stratified clinical trials.


Subject(s)
Carcinoma, Adenoid Cystic/pathology , Neoplasm Metastasis/pathology , Submandibular Gland Neoplasms/pathology , Biopsy , Diaphragm/pathology , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Pericardium/pathology , Salivary Glands/pathology
6.
J Am Soc Cytopathol ; 9(5): 442-449, 2020.
Article in English | MEDLINE | ID: mdl-32654990

ABSTRACT

INTRODUCTION: Pediatric bone and soft tissue (BST) lesions typically undergo biopsy prior to treatment, which commonly involves core needle biopsy (CNB) and/or fine-needle aspiration biopsy (FNAB). This study looks at the utility of small biopsies in the current diagnosis of pediatric BST lesions from 2 institutions. MATERIALS AND METHODS: A retrospective search of BST small biopsies obtained during a 2-year time period (2018-2019) at 2 academic institutions was performed to look at clinicopathologic features, biopsy diagnoses, and correlation with follow-up. RESULTS: A total of 96 pediatric patients (average age 11.2 years, range: 10 months-19 years) with BST lesions underwent a small biopsy, which represents 5% of the total BST lesions biopsied. The results show that the majority of lesions were benign (65%), and diagnosed by CNB alone (73%); a combination of FNAB and CNB (16%), and FNAB alone (11%), were less frequent. The CNB was effective in making a definitive diagnosis in 93% of cases and overall small biopsy was effective in 91% of the cases. Cases with definitive diagnoses on small biopsy were more likely to have concurrent CNB or characteristic ancillary studies performed. CONCLUSIONS: Although pediatric BST lesions constitute only 5% of all BST lesions biopsied, minimally invasive small biopsies with cytologic evaluation for triage and appropriate ancillary study utilization can help render specific diagnoses that help to determine the appropriate treatment for young patients with BST lesions. The current diagnostic approach frequently involves CNB with intraprocedural evaluation or concurrent FNAB, with fewer biopsied by FNAB alone.


Subject(s)
Bone Neoplasms/diagnosis , Soft Tissue Neoplasms/diagnosis , Triage/methods , Adolescent , Biopsy, Fine-Needle/methods , Biopsy, Large-Core Needle/methods , Bone Neoplasms/pathology , Bone and Bones/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Hospitals, Pediatric , Humans , Infant , Male , Retrospective Studies , Sensitivity and Specificity , Soft Tissue Neoplasms/pathology , Young Adult
7.
BMC Cancer ; 20(1): 535, 2020 Jun 08.
Article in English | MEDLINE | ID: mdl-32513132

ABSTRACT

BACKGROUND: Expression of forkhead box P3 (FOXP3), a key regulator of T-cell function, in the tumor immune microenvironment is related to survival in classic Hodgkin lymphoma (CHL). Vitamin D receptor (VDR), a transcription factor agonists have been shown to induce FOXP3 expression in T-cells and enhance recruitment of these cells to the inflammatory sites. VDR expression is CHL has been described. However, there is no data on expression of VDR in context of quantity of FOXP3 positive cells in CHL. METHODS: We examined and correlated immunohistochemical expression of VDR and FOXP3 along with clinical and pathology findings in 29 cases of CHL. RESULTS: VDR was expressed in Hodgkin Reed-Sternberg (HRS) cells and background lymphocytes and FOXP3 was expressed in background lymphocytes. 82% of CHL cases, regardless of the subtype, expressed VDR and in majority of the cases, VDR expression was directly proportional to the quantity of FOXP3 expressing lymphocytes in the tumor microenvironment. In cases with higher clinical stage (III/IV), only 28.5% of cases diffusely expressed VDR and FOXP3 compared to 71.4% showing focal positivity. Whereas in cases with lower clinical stages (I/II), the expression pattern of VDR and FOXP3 was almost similar (41.6% diffuse versus 33.3% focal). Interestingly, focal VDR and FOXP3 expression pattern was significantly higher among males. Mixed cellularity cases showed predilection for focal VDR and FOXP3 expression (80% cases); whereas nodular sclerosis subtype had focal and diffuse VDR and FOXP3 expression patterns in similar proportion. Cases with diffuse VDR and FOXP3 expression were less likely to have bone marrow involvement. Epstein Barr virus- encoded small RNA (EBER) positive cases were predominantly focally positive (80%) for VDR and FOXP3. CONCLUSIONS: In summary, quantity of FOXP3 positive T-cells in CHL microenvironment seems to correlate with VDR expression. Clinical stage show a trend of inverse correlation with expression of VDR and quantity of FOXP3 positive T-cells. These findings suggest that VDR could be a possible prognostic and therapeutic target in CHL.


Subject(s)
Biomarkers, Tumor/metabolism , Forkhead Transcription Factors/metabolism , Hodgkin Disease/pathology , Receptors, Calcitriol/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Bone Marrow/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Forkhead Transcription Factors/analysis , Hodgkin Disease/mortality , Hodgkin Disease/therapy , Humans , Immunohistochemistry , Lymph Nodes/cytology , Lymph Nodes/pathology , Male , Middle Aged , Prognosis , Receptors, Calcitriol/analysis , Reed-Sternberg Cells/metabolism , Reed-Sternberg Cells/pathology , Sex Factors , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Treatment Outcome , Tumor Microenvironment , Young Adult
9.
PLoS One ; 11(6): e0156857, 2016.
Article in English | MEDLINE | ID: mdl-27271180

ABSTRACT

Vitamin D is a fat-soluble steroid hormone that activates vitamin D receptor to regulate multiple downstream signaling pathways and transcription of various target genes. There is an association between vitamin D deficiency and increased risk for cardiovascular disease. However, most of the studies are observational and associative in nature with limited data on clinical application. Thus, there is a need for more prospective randomized controlled studies to determine whether or not vitamin D supplementation provides cardiovascular protection. In this study, we examined the effects of the deficiency and supplementation of vitamin D on coronary restenosis following coronary intervention in atherosclerotic Yucatan microswine. Twelve Yucatan microswine were fed vitamin D-deficient (n = 4) or -sufficient (n = 8) high cholesterol diet for 6-months followed by coronary intervention. Post-intervention, swine in the vitamin D-sufficient high cholesterol diet group received daily oral supplementation of either 1,000 IU (n = 4) or 3,000 IU (n = 4) vitamin D3. Six months later, optical coherence tomography (OCT) was performed to monitor the development of intimal hyperplasia and restenosis. Animals were euthanized to isolate arteries for histomorphometric and immunohistochemical studies. Animals had graded levels of serum 25(OH)D; vitamin D-deficient (15.33 ± 1.45 ng/ml), vitamin D-sufficient + 1,000 IU oral vitamin D post-intervention (32.27 ± 1.20 ng/ml), and vitamin D-sufficient + 3,000 IU oral vitamin D post-intervention (51.00 ± 3.47 ng/ml). Findings from the OCT and histomorphometric studies showed a decrease in intimal hyperplasia and restenosis in vitamin D-supplemented compared to vitamin D-deficient swine. Vitamin D supplementation significantly decreased serum levels of TNF-α and IFN-γ, upregulated serum levels of IL-10, and had no effect on serum IL-6 levels. These findings suggest that vitamin D supplementation limits neointimal formation following coronary intervention in atherosclerotic swine and provide the support for vitamin D supplementation to protect against the development of coronary restenosis.


Subject(s)
Coronary Artery Disease/surgery , Coronary Restenosis/prevention & control , Percutaneous Coronary Intervention , Tunica Intima/drug effects , Tunica Intima/pathology , Vitamin D Deficiency/drug therapy , Vitamin D/therapeutic use , Animals , Coronary Artery Disease/pathology , Coronary Restenosis/etiology , Dietary Supplements , Disease Models, Animal , Hyperplasia/prevention & control , Percutaneous Coronary Intervention/adverse effects , Swine , Vitamin D Deficiency/complications , Vitamin D Deficiency/pathology
10.
Endocr Pathol ; 27(1): 21-4, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26318442

ABSTRACT

Mediastinal teratomas with elements of mature pancreatic tissue are rare. Only a very few cases of pancreatic tissue with nesidioblastosis in teratoma have been reported. Here, we report a case of a 12-year-old male who presented with pleural effusion and was revealed to have a large anterior mediastinal mass. Biopsy of the mass revealed benign mature teratoma. After biopsy, the teratoma ruptured into the right thoracic cavity. It was then excised and sent to pathology for further evaluation. Preoperatively, there was no evidence of hyperinsulinemia or hypoglycemia. Postoperatively, there was no change in blood glucose levels. Histologically, the mass showed large areas of mature pancreatic tissue flanking a small intestine-like structure. Numerous endocrine cell islets, poorly defined groups of neuroendocrine cells and ductular-insular complexes characteristic of nesidioblastosis were dispersed in the exocrine pancreatic parenchyma. In addition, other parts of the tumor containing keratinizing squamous epithelium with cutaneous adnexal glands, small intestine, and bronchus including cartilage and respiratory epithelium were observed. Some islets contained two or more cell types while others were monophenotypic. Immunohistochemical staining showed pronounced expression of pancreatic polypeptide, moderate expression of somatostatin and insulin and nearly complete absence of glucagon-containing cells. The selective deletion of glucagon might hold clues to an important regulatory mechanism in pancreatic development.


Subject(s)
Mediastinal Neoplasms/pathology , Pancreas/pathology , Teratoma/pathology , Biomarkers, Tumor/analysis , Cell Differentiation , Child , Glucagon/metabolism , Humans , Immunohistochemistry , Islets of Langerhans/pathology , Male , Nesidioblastosis/pathology
11.
Nanomedicine (Lond) ; 10(15): 2379-404, 2015.
Article in English | MEDLINE | ID: mdl-26305189

ABSTRACT

The relentless advance of drug-resistance among pathogenic microbes, mandates a search for alternative approaches that will not cause resistance. Photodynamic inactivation (PDI) involves the combination of nontoxic dyes with harmless visible light to produce reactive oxygen species that can selectively kill microbial cells. PDI can be broad-spectrum in nature and can also destroy microbial cells in biofilms. Many different kinds of nanoparticles have been studied to potentiate antimicrobial PDI by improving photosensitizer solubility, photochemistry, photophysics and targeting. This review will cover photocatalytic disinfection with titania nanoparticles, carbon nanomaterials (fullerenes, carbon nanotubes and graphene), liposomes and polymeric nanoparticles. Natural polymers (chitosan and cellulose), gold and silver plasmonic nanoparticles, mesoporous silica, magnetic and upconverting nanoparticles have all been used for PDI.


Subject(s)
Bacteria/radiation effects , Light , Nanomedicine , Photochemotherapy , Catalysis , Microbial Sensitivity Tests
12.
Curr Pharm Des ; 21(16): 2109-21, 2015.
Article in English | MEDLINE | ID: mdl-25760339

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) has become the most important drug-resistant microbial pathogen in countries throughout the world. Morbidity and mortality due to MRSA infections continue to increase despite efforts to improve infection control measures and to develop new antibiotics. Therefore alternative antimicrobial strategies that do not give rise to development of resistance are urgently required. A group of therapeutic interventions has been developed in the field of photomedicine with the common theme that they rely on electromagnetic radiation with wavelengths between 200 and 1000 nm broadly called "light". These techniques all use simple absorption of photons by specific chromophores to deliver the killing blow to microbial cells while leaving the surrounding host mammalian cells relatively unharmed. Photodynamic inactivation uses dyes called photosensitizers (PS) that bind specifically to MRSA cells and not host cells, and generate reactive oxygen species including singlet oxygen and singlet oxygen upon illumination. Sophisticated molecular strategies to target the PS to MRSA cells have been designed. Ultraviolet C radiation can damage microbial DNA without unduly harming host DNA. Blue light can excite endogenous porphyrins and flavins in MRSA cells that are not present in host cells. Near-infrared lasers can interfere with microbial membrane potentials without raising the temperature of the tissue. Taken together these innovative approaches towards harnessing the power of light suggest that the ongoing threat of MRSA may eventually be defeated.


Subject(s)
Light , Methicillin-Resistant Staphylococcus aureus/drug effects , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Staphylococcal Infections/drug therapy , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Humans , Laser Therapy/methods , Photosensitizing Agents/pharmacology , Reactive Oxygen Species/metabolism , Staphylococcal Infections/diagnosis , Staphylococcus aureus/drug effects , Treatment Outcome , Ultraviolet Therapy/methods
13.
J Biophotonics ; 8(6): 502-11, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25196192

ABSTRACT

Transcranial low-level laser (light) therapy (LLLT) is a new non-invasive approach to treating a range of brain disorders including traumatic brain injury (TBI). We (and others) have shown that applying near-infrared light to the head of animals that have suffered TBI produces improvement in neurological functioning, lessens the size of the brain lesion, reduces neuroinflammation, and stimulates the formation of new neurons. In the present study we used a controlled cortical impact TBI in mice and treated the mice either once (4 h post-TBI, 1-laser), or three daily applications (3-laser) with 810 nm CW laser 36 J/cm(2) at 50 mW/cm(2). Similar to previous studies, the neurological severity score improved in laser-treated mice compared to untreated TBI mice at day 14 and continued to further improve at days 21 and 28 with 3-laser being better than 1-laser. Mice were sacrificed at days 7 and 28 and brains removed for immunofluorescence analysis. Brain-derived neurotrophic factor (BDNF) was significantly upregulated by laser treatment in the dentate gyrus of the hippocampus (DG) and the subventricular zone (SVZ) but not in the perilesional cortex (lesion) at day 7 but not at day 28. Synapsin-1 (a marker for synaptogenesis, the formation of new connections between existing neurons) was significantly upregulated in lesion and SVZ but not DG, at 28 days but not 7 days. The data suggest that the benefit of LLLT to the brain is partly mediated by stimulation of BDNF production, which may in turn encourage synaptogenesis. Moreover the pleiotropic benefits of BDNF in the brain suggest LLLT may have wider applications to neurodegenerative and psychiatric disorders. Neurological Severity Score (NSS) for TBI mice.


Subject(s)
Brain Injuries/radiotherapy , Brain-Derived Neurotrophic Factor/metabolism , Dentate Gyrus/radiation effects , Lateral Ventricles/radiation effects , Low-Level Light Therapy/methods , Synapsins/metabolism , Animals , Brain Injuries/physiopathology , Dentate Gyrus/metabolism , Disease Models, Animal , Fluorescent Antibody Technique , Lateral Ventricles/metabolism , Male , Mice, Inbred BALB C , Severity of Illness Index , Synapses/metabolism , Synapses/radiation effects , Treatment Outcome
14.
J Biomed Nanotechnol ; 10(9): 1918-36, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25544837

ABSTRACT

Since the discovery of C60 fullerene in 1985, scientists have been searching for biomedical applications of this most fascinating of molecules. The unique photophysical and photochemical properties of C60 suggested that the molecule would function well as a photosensitizer in photodynamic therapy (PDT). PDT uses the combination of non-toxic dyes and harmless visible light to produce reactive oxygen species that kill unwanted cells. However the extreme insolubility and hydrophobicity of pristine CO60, mandated that the cage be functionalized with chemical groups that provided water solubility and biological targeting ability. It has been found that cationic quaternary ammonium groups provide both these features, and this review covers work on the use of cationic fullerenes to mediate destruction of cancer cells and pathogenic microorganisms in vitro and describes the treatment of tumors and microbial infections in mouse models. The design, synthesis, and use of simple pyrrolidinium salts, more complex decacationic chains, and light-harvesting antennae that can be attached to C60, C70 and C84 cages are covered. In the case of bacterial wound infections mice can be saved from certain death by fullerene-mediated PDT.


Subject(s)
Fullerenes/therapeutic use , Photochemotherapy , Animals , Anti-Infective Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Humans , Neoplasms/drug therapy , Photosensitizing Agents/therapeutic use
15.
Dose Response ; 12(4): 619-49, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25552961

ABSTRACT

Pre-conditioning by ischemia, hyperthermia, hypothermia, hyperbaric oxygen (and numerous other modalities) is a rapidly growing area of investigation that is used in pathological conditions where tissue damage may be expected. The damage caused by surgery, heart attack, or stroke can be mitigated by pre-treating the local or distant tissue with low levels of a stress-inducing stimulus, that can induce a protective response against subsequent major damage. Low-level laser (light) therapy (LLLT) has been used for nearly 50 years to enhance tissue healing and to relieve pain, inflammation and swelling. The photons are absorbed in cytochrome(c) oxidase (unit four in the mitochondrial respiratory chain), and this enzyme activation increases electron transport, respiration, oxygen consumption and ATP production. A complex signaling cascade is initiated leading to activation of transcription factors and up- and down-regulation of numerous genes. Recently it has become apparent that LLLT can also be effective if delivered to normal cells or tissue before the actual insult or trauma, in a pre-conditioning mode. Muscles are protected, nerves feel less pain, and LLLT can protect against a subsequent heart attack. These examples point the way to wider use of LLLT as a pre-conditioning modality to prevent pain and increase healing after surgical/medical procedures and possibly to increase athletic performance.

16.
PLoS One ; 7(8): e42789, 2012.
Article in English | MEDLINE | ID: mdl-22880111

ABSTRACT

BACKGROUND: Inflammatory cytokines, such as TNF-α, play a key role in the pathogenesis of occlusive vascular diseases. Activation of vitamin D receptors (VDR) elicits both growth-inhibitory and anti-inflammatory effects. Here, we investigated the expression of TNF-α and VDR in post-angioplasty coronary artery neointimal lesions of hypercholesterolemic swine and examined the effect of vitamin D deficiency on the development of coronary restenosis. We also examined the effect of calcitriol on cell proliferation and effect of TNF-α on VDR activity and expression in porcine coronary artery smooth muscle cells (PCASMCs) in-vitro. METHODOLOGY/PRINCIPAL FINDINGS: Expression of VDR and TNF-α and the effect of vitamin D deficiency in post-angioplasty coronary arteries were analyzed by immunohistochemistry and histomorphometry. Cell proliferation was examined by thymidine and BrdU incorporation assays in cultured PCASMCs. Effect of TNF-α-stimulation on the activity and expression of VDR was analyzed by luciferase assay, immunoblotting and immunocytochemistry. In-vivo, morphometric analysis of the tissues revealed typical lesions with significant neointimal proliferation. Histological evaluation showed expression of smooth muscle α-actin and significantly increased expression of TNF-α in neointimal lesions. Interestingly, there was significantly decreased expression of VDR in PCASMCs of neointimal region compared to normal media. Indeed, post-balloon angioplasty restenosis was significantly higher in vitamin D-deficient hypercholesterolemic swine compared to vitamin D-sufficient group. In-vitro, calcitriol inhibited both serum- and PDGF-BB-induced proliferation in PCASMCs and TNF-α-stimulation significantly decreased the expression and activity of VDR in PCASMCs. CONCLUSIONS/SIGNIFICANCE: These data suggest that significant downregulation of VDR in proliferating smooth muscle cells in neointimal lesions could be due to atherogenic cytokines, including TNF-α. Vitamin D deficiency potentiates the development of coronary restenosis. Calcitriol has anti-proliferative properties in PCASMCs and these actions are mediated through VDR. This could be a potential mechanism for uncontrolled growth of neointimal cells in injured arteries leading to restenosis.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Atherosclerosis/therapy , Coronary Vessels/pathology , Coronary Vessels/surgery , Neointima/etiology , Neointima/pathology , Receptors, Calcitriol/metabolism , Animals , Apoptosis/drug effects , Atherosclerosis/blood , Atherosclerosis/pathology , Becaplermin , Calcitriol/pharmacology , Cell Proliferation/drug effects , Coronary Restenosis/blood , Coronary Restenosis/etiology , Coronary Restenosis/pathology , Coronary Vessels/drug effects , Disease Models, Animal , Gene Knockdown Techniques , Hyperplasia , Lipids/blood , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , Neointima/blood , Proto-Oncogene Proteins c-sis/pharmacology , RNA, Small Interfering/metabolism , Receptors, Calcitriol/genetics , Sus scrofa/surgery , Transcription, Genetic/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Vitamin D/metabolism
17.
J Clin Immunol ; 32(5): 1093-103, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22526597

ABSTRACT

PURPOSE: A potent immunomodulatory role of Vitamin D in both innate and adaptive immunity has recently been appreciated. In allergic asthma, activation of NF-кB induces transcription of various cytokines and chemokines involved in allergic airway inflammation. The nuclear import of activated NF-кB p50/RelA subunit is dependent on importin α3 (KPNA4) and importin α4 (KPNA3). In this study, we examined the role of importin α3 in immunomodulatory effect of calcitriol in human bronchial smooth muscle cells (HBSMCs). METHODS: Cultured HBSMCs were stimulated with calcitriol in the presence and absence of cytokines, TNF-α, IL-1ß, and IL-10. The mRNA transcripts of importin α3 and α4 were analyzed using qPCR while protein expression of importin α3, α4 and nuclear RelA was analyzed by immunoblotting. RESULTS: Calcitriol significantly decreased mRNA and protein expression of importin α3 as well as nuclear protein expression of NF-кB p65 (RelA). The decreased activation of RelA by calcitriol was confirmed by decreased release of RelA-inducible molecules, including IL-5, IL-6 and IL-8, by HBSMCs upon calcitriol treatment. Calcitriol attenuated the effect of TNF-α and IL-1ß to upregulate mRNA and protein expression of importin α3. IL-10 significantly decreased the TNF-α induced expression of importin α3 and this effect was further potentiated by calcitriol. CONCLUSIONS: These data suggest that under inflammatory conditions, calcitriol decreases the expression of importin α3 resulting in decreased nuclear import of activated RelA. This could be a novel mechanism by which calcitriol could exert its immunomodulatory effects to reduce allergic airway inflammation and thus may alleviate the symptoms in allergic asthma.


Subject(s)
Calcitriol/pharmacology , Immunologic Factors/pharmacology , Myocytes, Smooth Muscle/drug effects , Transcription Factor RelA/genetics , alpha Karyopherins/genetics , Bronchi/cytology , Cells, Cultured , Cytokines/genetics , Cytokines/pharmacology , Humans , Myocytes, Smooth Muscle/metabolism , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , Receptors, Calcitriol/genetics
18.
Exp Mol Pathol ; 93(1): 82-90, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22537546

ABSTRACT

INTRODUCTION: Vitamin D is a sectosteroid that functions through Vitamin D receptor (VDR), a transcription factor, which controls the transcription of many targets genes. Vitamin D deficiency has been linked with cardiovascular diseases, including heart failure and coronary artery disease. Suppressor of cytokine signaling (SOCS)3 regulates different biological processes such as inflammation and cellular differentiation and is an endogenous negative regulator of cardiac hypertrophy. OBJECTIVE: The purpose of this study was to test the hypothesis that vitamin D deficiency causes cardiomyocyte hypertrophy and increased proinflammatory profile in epicardial adipose tissue (EAT), and this correlates with decreased expression of SOCS3 in cardiomyocytes and EAT. METHODS: Eight female Yucatan miniswine were fed vitamin D-sufficient (900 IU/d) or vitamin D-deficient hypercholesterolemic diet. Lipid profile, metabolic panel, and serum 25(OH)D levels were regularly measured. After 12 months animals were euthanized and histological, immunohistochemical and qPCR studies were performed on myocardium and epicardial fat. RESULTS: Histological studies showed cardiac hypertrophy, as judged by cardiac myocyte cross sectional area, in the vitamin D-deficient group. Immunohistochemical and qPCR analyses showed significantly decreased mRNA and protein expression of VDR and SOCS3 in cardiomyocytes of vitamin D-deficient animals. EAT from vitamin D-deficient group had significantly higher expression of TNF-α, IL-6, MCP-1, and decreased adiponectin in association with increased inflammatory cellular infiltrate. Interestingly, EAT from vitamin D-deficient group had significantly decreased expression of SOCS3. CONCLUSION: These data suggest that vitamin D deficiency induces hypertrophy in cardiomyocytes which is associated with decreased expression of VDR and SOCS3. Vitamin D deficiency is also associated with increased inflammatory markers in EAT. Activity of VDR in the body is controlled through regulation of vitamin D metabolites. Therefore, restoration of VDR function by supplementation of VDR ligands in vitamin D-deficient population might be helpful in reducing inflammation and cardiovascular risk.


Subject(s)
Adipose Tissue/physiopathology , Cardiomegaly/physiopathology , Hypercholesterolemia/physiopathology , Pericarditis/physiopathology , Pericardium/physiopathology , Vitamin D Deficiency/physiopathology , Adiponectin/biosynthesis , Adipose Tissue/metabolism , Animals , Cardiomegaly/metabolism , Chemokine CCL2/biosynthesis , Female , Hypercholesterolemia/metabolism , Inflammation Mediators/analysis , Inflammation Mediators/metabolism , Interleukin-6/biosynthesis , Lipid Metabolism , Lipids/blood , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/physiology , Pericarditis/metabolism , Pericardium/metabolism , Receptors, Calcitriol/biosynthesis , Suppressor of Cytokine Signaling Proteins/biosynthesis , Swine , Tumor Necrosis Factor-alpha/biosynthesis , Vitamin D/blood , Vitamin D Deficiency/metabolism
19.
Exp Mol Pathol ; 93(1): 74-81, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22537547

ABSTRACT

AIMS: Asthma is one of the most common chronic inflammatory diseases of the airways. Calcitriol exerts its action through Vitamin D receptor (VDR), which is a high affinity nuclear receptor. VDR is a transcription factor that alters the transcription of target genes which are involved in a wide spectrum of biological responses. Lower serum vitamin D levels are associated with airway hyperresponsiveness and increased asthma severity. Prohibitin is a ubiquitously expressed protein localized to the cell and mitochondrial membranes and the nucleus. METHODS AND RESULTS: HBSMCs were cultured and treated with calcitriol and/or TNF-α. The mRNA and protein expression of prohibitin and VDR were analyzed using qPCR and immunoblotting, respectively. In the in vivo studies, female BALB/c mice were fed with special vitamin D-deficient or 2000IU/kg of vitamin D-supplemented diet for 13weeks. Mouse model of allergic airway inflammation was developed by OVA-sensitization and challenge. The expression pattern of TNF-α, prohibitin and VDR in the lung of OVA-sensitized mice was analyzed using immunofluorescence. Calcitriol significantly increased and TNF-α decreased the protein and mRNA expression of prohibitin and VDR in HBSMCs. There was significantly increased expression of TNF-α and decreased expression of VDR and prohibitin in the lung of vitamin D-deficient mouse model of allergic airway inflammation. CONCLUSION: These results suggest that under inflammatory conditions there is decreased expression of VDR resulting in decreased expression of prohibitin, which is a vitamin D target gene. Vitamin D deficiency causes increase in the expression of TNF-α, thereby increasing inflammation and decreases the expression of VDR and prohibitin. Supplementation with vitamin D might reduce the levels of TNF-α, thereby increasing the expression of VDR and prohibitin that could be responsible for reducing allergic airway inflammation.


Subject(s)
Asthma/metabolism , Lung/metabolism , Receptors, Calcitriol/biosynthesis , Repressor Proteins/biosynthesis , Vitamin D Deficiency/metabolism , Animals , Bronchi/metabolism , Calcitriol/pharmacology , Cells, Cultured , Female , Humans , Lung/drug effects , Mice , Mice, Inbred BALB C , Myocytes, Smooth Muscle/metabolism , Prohibitins , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/pharmacology
20.
Am J Respir Cell Mol Biol ; 43(5): 520-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-19933379

ABSTRACT

We previously reported that Fms-like tyrosine kinase 3 ligand (Flt3-L) reversed airway hyperresponsiveness (AHR) and airway inflammation, and increased the number of regulatory CD11c(high)CD8α(high)CD11b(low) dendritic cells and CD4(+)CD25(+)ICOS(+)Foxp3(+)IL-10(+) T-regulatory cells in the lung of allergen-sensitized and -challenged mice. In this study, we evaluated the effect of Flt3-L on Th17 cells and expression of suppressors of cytokine signaling (SOCS) proteins in the lungs of house dust mite (HDM)-sensitized and -challenged mice. BALB/c mice were sensitized and challenged with HDM, and AHR to methacholine was established. Mice were treated with Flt3-L (5 µg, intraperitoneal) daily for 10 days. Levels of IL-4, -5, -6, -8, and -13, and transforming growth factor (TGF)-ß in the bronchoalveolar lavage fluid (BALF) were examined by ELISA. Flt3-L treatment reversed existing AHR to methacholine and substantially decreased eosinophils, neutrophils, IL-5, -6, -8, and IL-13, and TGF-ß levels in the BALF. HDM-sensitized and -challenged mice showed a significant increase in lung CD4(+)IL-17(+)IL-23R(+)CD25⁻ T cells with high expression of retinoic acid-related orphan receptor (ROR)-γt transcripts. However, administration of Flt3-L substantially decreased the number of lung CD4(+)IL-17(+)IL-23R(+)CD25⁻ T cells, with significantly decreased expression of ROR-γt mRNA in these cells. HDM sensitization caused a significant increase in the expression of SOCS-1, -3, and -5 in the lung. Flt3-L treatment abolished the increase in SOCS-1 and SOCS-3 proteins, whereas SOCS-5 expression was significantly reduced. These data suggest that the therapeutic effect of Flt3-L in reversing the hallmarks of allergic asthma in a mouse model is mediated by decreasing IL-6 and TGF-ß levels in the BALF, which, in turn, decrease CD4(+)IL-17(+)IL-23R(+)ROR-γt(+)CD25⁻ T cells and the expression of SOCS-1 and SOCS-3 in the lung of HDM-sensitized and -challenged mice.


Subject(s)
Immunization , Lung/immunology , Lung/parasitology , Membrane Proteins/pharmacology , Pyroglyphidae/immunology , Suppressor of Cytokine Signaling Proteins/metabolism , T-Lymphocytes, Helper-Inducer/immunology , Animals , Bronchial Hyperreactivity/immunology , Bronchial Hyperreactivity/pathology , Bronchoalveolar Lavage Fluid/cytology , CD4 Antigens/metabolism , Cell Count , Cell Separation , Cytokines/biosynthesis , Gene Expression Regulation/drug effects , Interleukin-2 Receptor alpha Subunit/metabolism , Lung/drug effects , Lung/pathology , Methacholine Chloride/pharmacology , Mice , Mice, Inbred BALB C , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Pyroglyphidae/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Interleukin/metabolism , T-Lymphocytes, Helper-Inducer/cytology , T-Lymphocytes, Helper-Inducer/drug effects , Th2 Cells/drug effects , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...